Skip to main content
Clinical Trials/NCT02280226
NCT02280226CompletedNot Applicable

Evaluating the Influence of Apnea on Heart Function With Strain Analysis and Measurement of Fibrosis Derived From T1-mapping Using Cardiac Magnetic Resonance Imaging (MRI).

University Hospital, Bonn0 sites17 target enrollmentStarted: April 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
17
Primary Endpoint
Cardiac Function: Duration of Apnea

Study Overview

Brief Summary

Former studies revealed a distinct pattern of changes in circulation during deliberate apnea. Blood pressure rises significantly often accompanied by bradycardia. Further studies confirmed a massive increase of total vascular resistance as it also happens in shock to maintain perfusion of heart, lung and brain. This study is to determine the exact alterations of the cardiac function during this reaction, show the redistribution of blood volume in apnea and evaluate possible longterm effects on the central nervous system caused by repeated apnea via magnetic resonance imaging.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
16 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Being able to hold breath deliberately at least 4,5 minutes

Exclusion Criteria

  • Not provided

Arms & Interventions

Deliberate Apnea Group

Experimental

Subjects undergo maximum apnea.

Intervention: magnetic resonance imaging (MRI) (Device)

Outcomes

Primary Outcomes

Cardiac Function: Duration of Apnea

Time Frame: every minute under apnea (from 0 up to 9 minutes and rest) depending on personal best with a mean of 5 measurements

Alteration of cardiac function in subjects undergoing maximum apnea.

Mean Blood Flow Measurement Under Apnea Using MRI

Time Frame: Every minute under apnea (from 0 up to 9 minutes and rest) depending on personal best with a mean of 5 measurements

Blood flow pattern in subjects undergoing maximum apnea.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Bonn
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jonas Doerner

MD

University Hospital, Bonn

Similar Trials